• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 10/4/24: Regulatory Challenges With Data Collection, Poor Sleep Quality Linked to Dementia & more

News
Article

The latest news for pharma industry insiders.

Regulatory Challenges With Data Collection

In this video interview with ACT editor Andy Studna, Erin Erginer, director of product, Certara discusses the lack of submission standards for clinical data.

Poor Sleep Quality and Dementia Linked With Mortality Risk

Poor sleep quality is directly related to mortality risk before adjusting for lifestyle or health-related factors, and dementia was noticeably linked to mortality risk in older White males.

Pay Rises for Cyber Chiefs as Hacks, Regulatory Pressure Increase

Average compensation for U.S.-based chief information security officers is now $565,000.

Dr. Wouter Latour Joins PharmaJet as Chief Executive Officer

PharmaJet® announced that Wouter Latour, M.D., has joined the company as Chief Executive Officer (CEO). Latour also joins the PharmaJet board of directors. He succeeds Chris Cappello who has recently been elected Vice-Chairman of the Board and will remain active in the business, largely focused on strategic partners and supporting engineering/operations.

Steve Blazevich on LinkedIn

Congrats to Elyse Blazevich and the CBSA Team plus its members for raising LS in CO to new heights!

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs